Alembic Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALEMBIC, and what generic and branded alternatives to ALEMBIC drugs are available?
ALEMBIC has one hundred and seventy-four approved drugs.
There are eleven tentative approvals on ALEMBIC drugs.
Summary for Alembic
US Patents: | 0 |
Tradenames: | 136 |
Ingredients: | 135 |
NDAs: | 174 |
Patent Litigation for Alembic: | See patent lawsuits for Alembic |
PTAB Cases with Alembic as petitioner: | See PTAB cases with Alembic as petitioner |
Drugs and US Patents for Alembic
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alembic | DEFERASIROX | deferasirox | TABLET;ORAL | 211824-001 | Nov 20, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Alembic Pharms Ltd | DESVENLAFAXINE | desvenlafaxine | TABLET, EXTENDED RELEASE;ORAL | 204150-002 | Mar 4, 2013 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Alembic | CLONAZEPAM | clonazepam | TABLET, ORALLY DISINTEGRATING;ORAL | 211033-003 | Jun 28, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Alembic | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 208705-001 | May 12, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Alembic | ERYTHROMYCIN | erythromycin | TABLET;ORAL | 215661-002 | Aug 24, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.